Market Place
Sourcing Support
Amgen to Present at The 2025 Wells Fargo Healthcare Conference
30 Aug 2025 //
PR NEWSWIRE
FDA Expands Repatha Use to Adults at Risk of Cardiovascular Event
28 Aug 2025 //
INDPHARMAPOST
Veeva Partners Global Bio to Advance Clinical Trial Innovation
28 Aug 2025 //
PR NEWSWIRE
Horizon’s Biologics Tepezza Receives Suppl Approval in US
26 Aug 2025 //
FDA
BeOne Bags $885 M in Royalty Deal on Amgen`s Imdelltra
26 Aug 2025 //
FIERCE PHARMA
Amgen’s Biologics Avsola Recieves Suppl Approval in US
25 Aug 2025 //
FDA
Amgen Expands Repatha® Use for High Cardiovascular Risk in Adults
25 Aug 2025 //
PR NEWSWIRE
Amgen`s ChemoCentryx Wins Investor Lawsuit
19 Aug 2025 //
FIERCE PHARMA
Amgen Finds Relief in Blincyto Patent Dispute with Lindis
15 Aug 2025 //
FIERCE PHARMA
Judge Overturns Amgen`s $50.3 M Loss in Cancer Drug Patent Case
15 Aug 2025 //
REUTERS
Rare Disease Clinical Progress Boosts Long-Term Revenue Potential
07 Aug 2025 //
PR NEWSWIRE
Amgen Reports Second Quarter 2025 Financial Results
06 Aug 2025 //
PR NEWSWIRE
Ex-Amgen SVP Ray Joins Iambic`s Scientific Advisory Board
05 Aug 2025 //
BUSINESSWIRE
Amgen Announces 2025 Third Quarter Dividend
01 Aug 2025 //
PR NEWSWIRE
Amgen`s Q2 2025 Financial Results Webcast Announced
31 Jul 2025 //
PR NEWSWIRE
Kissei Pays Viridian $70M to Compete with Amgen in Japan
30 Jul 2025 //
FIERCE BIOTECH
Lawsuit Points to Alleged Misconduct at Amgen-Bought Biotech
25 Jul 2025 //
FIERCE PHARMA
Kyowa, Amgen, Sanofi Support Women`s Health Info Update
23 Jul 2025 //
FIERCE PHARMA
Amgen tackles dangers of LDL cholesterol in 1st documentary film
09 Jul 2025 //
FIERCE PHARMA
Amgen, Zai Say Stomach Cancer Candidate Hits Phase 3 Mark
01 Jul 2025 //
BIOSPACE
Amgen`s Phase 2 obesity study of monthly Maritide results at ADA
23 Jun 2025 //
PR NEWSWIRE
Immunex`s Biologics Enbrel Receives Suppl Approval in US
18 Jun 2025 //
FDA
Amgen to Present Maritide Data at ADA 85th Scientific Sessions
18 Jun 2025 //
PR NEWSWIRE
Amgen Drug Cuts Small Cell Lung Cancer Death risk by 40%
03 Jun 2025 //
FIERCE PHARMA
Amgen`s Biologics Amjevita Receives Suppl Approval in US
20 May 2025 //
FDA
Amgen owes Regeneron $407M after defeat in PCSK9 antitrust suit
17 May 2025 //
FIERCE PHARMA
Amgen`s Tepezza Granted Marketing Authorisation in UK
07 May 2025 //
BUSINESSWIRE
FDA lifts hold on Amgen`s phase 1 obesity study
03 May 2025 //
FIERCE BIOTECH
Amgen posts profit, says tax policy more effective than tariffs
02 May 2025 //
REUTERS
Amgen Report Q1 2025 Financial Result
01 May 2025 //
PR NEWSWIRE
Amgen`s Biologic Blincyto Receives Approval in US
29 Apr 2025 //
FDA
Amgen Announces Webcast for Q1 2025 Financial Results
28 Apr 2025 //
PR NEWSWIRE
Amgen to expand Ohio biotech manufacturing plant
26 Apr 2025 //
REUTERS
Amgen`s Biologic Bkemv Receives Suppl Approval in US
18 Apr 2025 //
FDA
Amgen`S 13-Year Ceo Robert Bradway Gains 8% Pay Hike To $24.4M
14 Apr 2025 //
FIERCE PHARMA
Sandoz sues Amgen over patient access to etanercept biosimilar
14 Apr 2025 //
GLOBENEWSWIRE
Imdelltra Shows Better Survival in Small Cell Lung Cancer
11 Apr 2025 //
PR NEWSWIRE
FDA approves Amgen`s Uplizna in IgG4-related disease
04 Apr 2025 //
ENDPOINTS
Enforcement Report - Week of March 26, 2025
26 Mar 2025 //
FDA
Amgen, Kyowa Kirin Report Ph3 Rocatinlimab Data In Atopic Dermatitis
08 Mar 2025 //
PR NEWSWIRE
Amgen’s late-stage obesity trials expected to read out in ‘27
08 Mar 2025 //
FIERCE BIOTECH
Tezspire Treats Chronic Sinus Symptoms With Nasal Polyps
03 Mar 2025 //
PR NEWSWIRE
AMGEN TO PRESENT AT THE 45TH ANNUAL TD COWEN HEALTH CARE CONFERENCE
28 Feb 2025 //
PR NEWSWIRE
Amgen to invest $200 million in India site, CEO says
24 Feb 2025 //
ECONOMICTIMES
Drugmaker Amgen to invest $200 million in India site, CEO says
24 Feb 2025 //
REUTERS
Amgen to Present at CITI`S 2025 Virtual oncology leadership summit
14 Feb 2025 //
PR NEWSWIRE
Amgen, Ideaya Call It Quits on Cancer Combo
14 Feb 2025 //
BIOSPACE
Accumulus Synergy Powers 1st Digitally Generated Dossier Worldwide
05 Feb 2025 //
GLOBENEWSWIRE
Amgen’s early-stage obesity asset put on clinical hold by FDA
05 Feb 2025 //
FIERCE BIOTECH
Amgen Reports Report Q4 and Full Year Financial Result
04 Feb 2025 //
PR NEWSWIRE
EU Approves Blincyto® In CD19+ B-Cell ALL Consolidation Phase
29 Jan 2025 //
PR NEWSWIRE
Amgen fends off Celltrion`s proposed Prolia biosim until June
29 Jan 2025 //
FIERCE PHARMA
New Treatments for Celiac Disease Gain Traction
21 Jan 2025 //
BIOSPACE
New Treatments for Celiac Disease Gain Traction
20 Jan 2025 //
BIOSPACE
FDA Approves Lumakras & Vectibix Combo For G12C Colorectal Cancer
17 Jan 2025 //
PR NEWSWIRE
FDA approves Amgen`s colorectal cancer therapy
17 Jan 2025 //
REUTERS
Sling`s oral Tepezza rival hits goal in thyroid eye disease, Ph 3
15 Jan 2025 //
PR NEWSWIRE
Sling`s oral Tepezza rival hits goal in thyroid eye disease
14 Jan 2025 //
FIERCE BIOTECH
CytomX lays off 40%, mulls future of Amgen-partnered drug
10 Jan 2025 //
FIERCE BIOTECH
Amgen’s IMDYLLTRA Gets UK Approval For Extensive-Stage Lung Cancer
06 Jan 2025 //
BUSINESSWIRE
